Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In Vivo.
Ontology highlight
ABSTRACT: Bupropion is a widely used antidepressant and smoking cessation aid in addition to being one of two US Food and Drug Administration-recommended probe substrates for evaluation of cytochrome P450 2B6 activity. Racemic bupropion undergoes oxidative and reductive metabolism, producing a complex profile of pharmacologically active metabolites with relatively little known about the mechanisms underlying their elimination. A liquid chromatography-tandem mass spectrometry assay was developed to simultaneously separate and detect glucuronide metabolites of (R,R)- and (S,S)-hydroxybupropion, (R,R)- and (S,S)-hydrobupropion (threo) and (S,R)- and (R,S)-hydrobupropion (erythro), in human urine and liver subcellular fractions to begin exploring mechanisms underlying enantioselective metabolism and eli
SUBMITTER: Gufford BT
PROVIDER: S-EPMC4810769 | biostudies-literature | 2016 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA